AVIR · Atea Pharmaceuticals, Inc.
$5.00
+0.25 (+5.26%)
At close · Aug 6
Market Cap
$399.34M
Shares
80.03M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$25,000,000
as of 2025-04-30
Remaining Authorization
$11,091,000
as of 2025-06-30
Program Utilization
55.6%
$13,909,000 used of $25,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $25,519,000 | 10-K, filed 2026-03-05 |
| 2024-12-31 | $0 | 10-K, filed 2026-03-05 |
Key facts
CIK
1593899
CUSIP
04683R106
13F (30d)
26 filings
26 filers
Visit website
Investor relations